Company Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
40 USD +1.34% Intraday chart for Qiagen N.V. -0.45% -10.66%

Business Summary

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Number of employees: 5,361

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumables and Related
87.8 %
1,889 88.2 % 1,726 87.8 % -8.61%
Instrumentation
12.2 %
253 11.8 % 239 12.2 % -5.34%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
47.6 %
910 42.5 % 935 47.6 % +2.82%
Europe, Middle East and Africa
30.7 %
702 32.8 % 604 30.7 % -13.92%
Asia Pacific, Japan and Rest of World
16.3 %
410 19.2 % 321 16.3 % -21.84%
Other Americas
4.3 %
88 4.1 % 85 4.3 % -3.82%
Netherlands
1.0 %
32 1.5 % 20 1.0 % -35.56%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 15-01-31
Founder 69 96-04-28
Director of Finance/CFO 56 98-12-31
Chief Operating Officer - 22-03-31
Compliance Officer 57 03-11-30
Compliance Officer - -
Investor Relations Contact - 10-09-30
Corporate Officer/Principal - -
Human Resources Officer - 04-12-31
Corporate Officer/Principal 52 17-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 74 11-05-31
Founder 69 96-04-28
Chairman 66 13-06-25
Director/Board Member 62 13-12-31
Director/Board Member 66 23-04-20
Director/Board Member 58 21-01-07
Director/Board Member 52 15-12-31
Director/Board Member 70 22-06-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 223,904,389 220,438,912 ( 98.45 %) 2,567,594 ( 1.147 %) 98.45 %

Shareholders

NameEquities%Valuation
Massachusetts Financial Services Co.
10.87 %
24,066,569 10.87 % 1 030 M $
Massachusetts Financial Services Co.
10.55 %
23,344,572 10.55 % 999 M $
Vanguard Fiduciary Trust Co.
3.863 %
8,551,004 3.863 % 366 M $
Wellington Management Co. LLP
3.187 %
7,053,673 3.187 % 302 M $
Norges Bank Investment Management
2.950 %
6,529,692 2.950 % 280 M $
BlackRock Advisors LLC
2.822 %
6,246,527 2.822 % 267 M $
CPR Asset Management SA
2.723 %
6,026,785 2.723 % 258 M $
Norges Bank (13F)
2.663 %
5,895,158 2.663 % 252 M $
MFS International (UK) Ltd.
2.394 %
5,300,035 2.394 % 227 M $
Fidelity Investments Canada ULC
2.234 %
4,946,167 2.234 % 212 M $

Company contact information

QIAGEN NV

Hulsterweg 82

5912 PL, Venlo

+31 77 355 6600

http://www.qiagen.com
address Qiagen N.V.(QGEN)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Packaged Software
Electronic Components
Qiagen AB
Medical/Nursing Services
Medical Specialties
Chemicals: Specialty
QIAGEN Singapore Pte Ltd.
Pharmaceuticals: Major